[1] | T. Adamiak and K. F. Plati, “Pediatric esophageal disorders: Diagnosis and treatment of reflux and eosinophilic esophagitis,” Pediatr. Rev., vol. 39, no. 8, pp. 392–402, Aug. 2018, doi: 10.1542/pir.2017-0266. |
[2] | S. J. Czinn and S. Blanchard, “Gastroesophageal reflux disease in neonates and infants: When and how to treat,” Pediatr. Drugs, vol. 15, no. 1, pp. 19–27, Feb. 2013, doi: 10.1007/s40272-012-0004-2. |
[3] | I. Davies, S. Burman-Roy, and M. S. Murphy, “Gastro-oesophageal reflux disease in children: NICE guidance,” BMJ, vol. 350, Jan. 2015, doi: 10.1136/bmj.g7703. |
[4] | R. N. Lopez and D. A. Lemberg, “Gastro-oesophageal reflux disease in infancy: a review based on international guidelines,” Med. J. Aust., vol. 212, no. 1, pp. 40–44, Jan. 2020, doi: 10.5694/mja2.50447. |
[5] | M. Singendonk et al., “Prevalence of Gastroesophageal Reflux Disease Symptoms in Infants and Children: A Systematic Review,” J. Pediatr. Gastroenterol. Nutr., vol. 68, no. 6, pp. 811–817, Jun. 2019, doi: 10.1097/MPG.0000000000002280. |
[6] | Y. Vandenplas et al., “Middle east consensus statement on the diagnosis and management of functional gastrointestinal disorders in < 12 months old infants,” Pediatr. Gastroenterol. Hepatol. Nutr., vol. 19, no. 3, pp. 153–161, 2016, doi: 10.5223/pghn.2016.19.3.153. |
[7] | G. Davidson, “The role of lower esophageal sphincter function and dysmotility in gastroesophageal reflux in premature infants and in the first year of life.,” J. Pediatr. Gastroenterol. Nutr., vol. 37 Suppl 1, 2003, doi: 10.1097/00005176-200311001-00005. |
[8] | T. I. Omari et al., “Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease,” Gut, vol. 51, no. 4, pp. 475–479, Oct. 2002, doi: 10.1136/gut.51.4.475. |
[9] | R. Rosen, “Gastroesophageal reflux in infants: More than just a pHenomenon,” JAMA Pediatr., vol. 168, no. 1, pp. 83–89, Jan. 2014, doi: 10.1001/jamapediatrics.2013.2911. |
[10] | S. R. Jadcherla, H. Q. Duong, R. G. Hoffmann, and R. Shaker, “Esophageal body and upper esophageal sphincter motor responses to esophageal provocation during maturation in preterm newborns,” J. Pediatr., vol. 143, no. 1, pp. 31–38, Jul. 2003, doi: 10.1016/S0022-3476(03)00242-7. |
[11] | A. M. Ravelli, P. Tobanelli, S. Volpi, and A. G. Ugazio, “Vomiting and gastric motility in infants with cow’s milk allergy,” J. Pediatr. Gastroenterol. Nutr., vol. 32, no. 1, pp. 59–64, 2001, doi: 10.1097/00005176-200101000-00017. |
[12] | D. C. Baird, D. J. Harker, A. S. Karmes, and D. R. Carl, “Diagnosis and Treatment of Gastroesophageal Reflux in Infants and Children,” Am. Fam. Physician, vol. 92, no. 8, pp. 705–714, Oct. 2015, Accessed: Apr. 01, 2021. [Online]. Available: www.aafp.org/afp. |
[13] | Y. Vandenplas et al., “Pediatric gastroesophageal reflux clinical practice guidelines: Joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN),” J. Pediatr. Gastroenterol. Nutr., vol. 49, no. 4, pp. 498–547, Oct. 2009, doi: 10.1097/MPG.0b013e3181b7f563. |
[14] | “Diagnosis of GER & GERD in Infants | NIDDK,” National Institute of Diabetes and Digestive and Kidney Diseases, Nov. 2020. http://33h.co/km7zg (accessed Apr. 02, 2021). |
[15] | R. J. Van Der Pol, M. J. Smits, L. Venmans, N. Boluyt, M. A. Benninga, and M. M. Tabbers, “Diagnostic accuracy of tests in pediatric gastroesophageal reflux disease,” J. Pediatr., vol. 162, no. 5, 2013, doi: 10.1016/j.jpeds.2012.10.041. |
[16] | S. M. Adams, C. E. Ward, and K. L. Garcia, “Sudden Infant Death Syndrome,” Am. Fam. Physician, vol. 91, no. 11, pp. 778–783, Jun. 2015, Accessed: Apr. 04, 2021. [Online]. Available: www.aafp.org/afp. |
[17] | J. R. Lightdale et al., “Gastroesophageal reflux: Management guidance for the pediatrician,” Pediatrics, vol. 131, no. 5, pp. e1684–e1695, May 2013, doi: 10.1542/peds.2013-0421. |
[18] | World Data, “Iraq: country data and statistics.” https://www.worlddata.info/asia/iraq/index.php (accessed Apr. 11, 2021). |
[19] | Unicef, “Iraq (IRQ) - Demographics, Health & Infant Mortality - UNICEF DATA.” https://data.unicef.org/country/irq/ (accessed Apr. 11, 2021). |
[20] | World Health Organization, “WHO EMRO | Maternal, newborn, child and adolescent health | Programmes | Iraq.” https://www.emro.who.int/irq/programmes/maternal-newborn-child-adolescent-health.html (accessed Apr. 11, 2021). |
[21] | M. A. Benninga, S. Nurko, C. Faure, P. E. Hyman, I. St James Roberts, and N. L. Schechter, “Childhood functional gastrointestinal disorders: Neonate/toddler,” Gastroenterology, vol. 150, no. 6, pp. 1443-1455.e2, May 2016, doi: 10.1053/j.gastro.2016.02.016. |
[22] | M. A. L. Van Tilburg et al., “Prevalence of functional gastrointestinal disorders in infants and toddlers,” J. Pediatr., vol. 166, no. 3, pp. 684–689, Mar. 2015, doi: 10.1016/j.jpeds.2014.11.039. |
[23] | S. P. Nelson, E. H. Chen, G. M. Syniar, and K. K. Christoffel, “Prevalence of symptoms of gastroesophageal reflux during infancy: A pediatric practice-based survey,” Arch. Pediatr. Adolesc. Med., vol. 151, no. 6, pp. 569–572, Jun. 1997, doi: 10.1001/archpedi.1997.02170430035007. |
[24] | N. F. Steutel et al., “Prevalence of Functional Gastrointestinal Disorders in European Infants and Toddlers,” J. Pediatr., vol. 221, pp. 107–114, Jun. 2020, doi: 10.1016/j.jpeds.2020.02.076. |
[25] | Mayo Clinic, “Spitting up in babies: What’s normal, what’s not - Mayo Clinic.” http://33h.co/km7zk (accessed Apr. 14, 2021). |
[26] | R. Rosen et al., “Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) HHS Public Access,” J Pediatr Gastroenterol Nutr, vol. 66, no. 3, pp. 516–554, 2018, doi: 10.1097/MPG.0000000000001889. |
[27] | Y. Vandenplas et al., “Functional gastro-intestinal disorder algorithms focus on early recognition, parental reassurance and nutritional strategies,” Acta Paediatr. Int. J. Paediatr., vol. 105, no. 3, pp. 244–252, Mar. 2016, doi: 10.1111/apa.13270. |
[28] | S. Salvatore and Y. Vandenplas, “Gastroesophageal reflux and cow milk allergy: Is there a link?,” Pediatrics, vol. 110, no. 5, pp. 972–984, Nov. 2002, doi: 10.1542/peds.110.5.972. |
[29] | C. Dupont and Y. Vandenplas, “Different thickening complexes with pectin in infant anti-regurgitation formula,” Acta Paediatr. Int. J. Paediatr., vol. 109, no. 3, pp. 471–480, Mar. 2020, doi: 10.1111/apa.15015. |
[30] | S. Salvatore et al., “Thickened infant formula: What to know,” Nutrition, vol. 49, pp. 51–56, May 2018, doi: 10.1016/j.nut.2017.10.010. |
[31] | B. Chevallier et al., “Intérêt d’une nouvelle préparation infantile dans la prise en charge des régurgitations du nourrisson,” Arch. Pediatr., vol. 16, no. 4, pp. 343–352, Apr. 2009, doi: 10.1016/j.arcped.2009.01.001. |
[32] | Y. Vandenplas, “Thickened infant formula does what it has to do: Decrease regurgitation,” Pediatrics, vol. 123, no. 3, Mar. 2009, doi: 10.1542/peds.2008-3815. |
[33] | V. Khoshoo, G. Ross, S. Brown, and D. Edell, “Smaller volume, thickened formulas in the management of gastroesophageal reflux in thriving infants,” J. Pediatr. Gastroenterol. Nutr., vol. 31, no. 5, pp. 554–556, 2000, doi: 10.1097/00005176-200011000-00018. |
[34] | J. Ramirez-Mayans et al., “Nutritional Management of Children with Gastroesophageal Reflux: A Comparison of Two Different Formulas,” Int. Pediatr., vol. 18, no. 2, pp. 78–83, 2003. |
[35] | Y. Vandenplas and L. Sacré, “Milk-Thickening Agents as a Treatment for Gastroesophageal Reflux,” Clin. Pediatr. (Phila)., vol. 26, no. 2, pp. 66–68, 1987, doi: 10.1177/000992288702600202. |
[36] | A. A. Moukarzel, H. Abdelnour, and C. Akatcherian, “Effects of a prethickened formula on esophageal pH and gastric emptying of infants with GER,” J. Clin. Gastroenterol., vol. 41, no. 9, pp. 823–829, Oct. 2007, doi: 10.1097/MCG.0b013e31802c2a10. |
[37] | I. Xinias et al., “Cornstarch thickened formula reduces oesophageal acid exposure time in infants,” Dig. Liver Dis., vol. 37, no. 1, pp. 23–27, Jan. 2005, doi: 10.1016/j.dld.2004.07.015. |
[38] | S. R. Orenstein, T. M. Shalaby, and P. E. Putnam, “Thickened feedings as a cause of increased coughing when used as therapy for gastroesophageal reflux in infants,” J. Pediatr., vol. 121, no. 6, pp. 913–915, 1992, doi: 10.1016/S0022-3476(05)80339-7. |
[39] | T. Shibata, C. Meng, J. Umoren, and H. West, “Risk assessment of arsenic in rice cereal and other dietary sources for infants and toddlers in the U.S,” Int. J. Environ. Res. Public Health, vol. 13, no. 4, Mar. 2016, doi: 10.3390/ijerph13040361. |
[40] | G. Iacono et al., “Clinical trial with thickened feeding for treatment of regurgitation in infants [2],” Dig. Liver Dis., vol. 34, no. 7, pp. 532–533, 2002, doi: 10.1016/S1590-8658(02)80115-3. |
[41] | R. Miyazawa, T. Tomomasa, H. Kaneko, and A. Morikawa, “Effect of formula thickened with locust bean gum on gastric emptying in infants,” J. Paediatr. Child Health, vol. 42, no. 12, pp. 808–812, Dec. 2006, doi: 10.1111/j.1440-1754.2006.00982.x. |
[42] | National Institute for Health and Care Excellence, “Gastro-oesophageal reflux disease in children and young people: diagnosis and management NICE guideline,” 2015. Accessed: Apr. 18, 2021. [Online]. Available: www.nice.org.uk/guidance/ng1. |
[43] | H. Mousa and M. Hassan, “Gastroesophageal Reflux Disease,” Pediatr. Clin. North Am., vol. 64, no. 3, pp. 487–505, Jun. 2017, doi: 10.1016/j.pcl.2017.01.003. |
[44] | A. Ruigómez, M. A. Wallander, P. Lundborg, S. Johansson, and L. A. G. Rodriguez, “Gastroesophageal reflux disease in children and adolescents in primary care,” Scand. J. Gastroenterol., vol. 45, no. 2, pp. 139–146, 2010, doi: 10.3109/00365520903428606. |
[45] | T. I. Omari et al., “Paradoxical impact of body positioning on gastroesophageal reflux and gastric emptying in the premature neonate,” J. Pediatr., vol. 145, no. 2, pp. 194–200, Aug. 2004, doi: 10.1016/j.jpeds.2004.05.026. |
[46] | M. P. van Wijk et al., “Effect of Body Position Changes on Postprandial Gastroesophageal Reflux and Gastric Emptying in the Healthy Premature Neonate,” J. Pediatr., vol. 151, no. 6, 2007, doi: 10.1016/j.jpeds.2007.06.015. |
[47] | R. Y. Moon, R. A. Darnall, L. Feldman-Winter, M. H. Goodstein, and F. R. Hauck, “SIDS and other sleep-related infant deaths: Updated 2016 recommendations for a safe infant sleeping environment,” Pediatrics, vol. 138, no. 5, Nov. 2016, doi: 10.1542/peds.2016-2938. |
[48] | L. Kleinman, D. A. Revicki, and E. Flood, “Validation issues in questionnaires for diagnosis and monitoring of gastroesophageal reflux disease in children,” Curr. Gastroenterol. Rep., vol. 8, no. 3, pp. 230–236, Jun. 2006, doi: 10.1007/s11894-006-0080-y. |
[49] | Y. Vandenplas, B. Leluyer, M. Cazaubiel, B. Housez, and A. Bocquet, “Double-blind comparative trial with 2 antiregurgitation formulae,” J. Pediatr. Gastroenterol. Nutr., vol. 57, no. 3, pp. 389–393, Sep. 2013, doi: 10.1097/MPG.0b013e318299993e. |
[50] | Y. Vandenplas and E. De Greef, “Extensive protein hydrolysate formula effectively reduces regurgitation in infants with positive and negative challenge tests for cow’s milk allergy,” Acta Paediatr. Int. J. Paediatr., vol. 103, no. 6, 2014, doi: 10.1111/apa.12615. |
[51] | CMS, “Proton Pump Inhibitors: Use in Pediatric Patients,” 2015. Accessed: Apr. 21, 2021. [Online]. Available: https://www.guideline.gov. |
[52] | P. De Bruyne and S. Ito, “Toxicity of long-term use of proton pump inhibitors in children,” Arch. Dis. Child., vol. 103, no. 1, pp. 78–82, 2018, doi: 10.1136/archdischild-2017-314026. |
[53] | C. M. Stark, A. Susi, J. Emerick, and C. M. Nylund, “Antibiotic and acid-suppression medications during early childhood are associated with obesity,” Gut, vol. 68, no. 1, pp. 62–69, Jan. 2019, doi: 10.1136/gutjnl-2017-314971. |
[54] | L. Malchodi, K. Wagner, A. Susi, G. Gorman, and E. Hisle-Gorman, “Early acid suppression therapy exposure and fracture in young children,” Pediatrics, vol. 144, no. 1, 2019, doi: 10.1542/peds.2018-2625. |
[55] | B. Lebwohl, S. J. Spechler, T. C. Wang, P. H. R. Green, and J. F. Ludvigsson, “Use of proton pump inhibitors and subsequent risk of celiac disease,” Dig. Liver Dis., vol. 46, no. 1, pp. 36–40, Jan. 2014, doi: 10.1016/j.dld.2013.08.128. |